Show simple item record

dc.contributor.authorPowell, Cen_US
dc.contributor.authorNewbold, Ken_US
dc.contributor.authorHarrington, KJen_US
dc.contributor.authorBhide, SAen_US
dc.contributor.authorNutting, CMen_US
dc.date.accessioned2018-06-05T14:31:44Z
dc.date.issued2010-08en_US
dc.identifier.citationClinical oncology (Royal College of Radiologists (Great Britain)), 2010, 22 (6), pp. 456 - 463en_US
dc.identifier.issn0936-6555en_US
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/1720
dc.identifier.eissn1433-2981en_US
dc.identifier.doi10.1016/j.clon.2010.03.012en_US
dc.description.abstractThe management of differentiated thyroid cancer involves a combination of surgery, thyroid stimulating hormone suppression and radioactive iodine for most patients. In a small subset of patients, external beam radiotherapy is also used. However, its role remains controversial and there are no randomised controlled trials to guide practice. In this overview we review the evidence from the published literature for the use of external beam radiotherapy in the management of differentiated thyroid cancer and discuss the indications for which it is most commonly used. The technique of external beam radiotherapy, including the emerging role for intensity-modulated radiotherapy, will also be discussed.en_US
dc.formatPrint-Electronicen_US
dc.format.extent456 - 463en_US
dc.languageengen_US
dc.language.isoengen_US
dc.subjectHumansen_US
dc.subjectThyroid Neoplasmsen_US
dc.subjectTreatment Outcomeen_US
dc.subjectRadiotherapy, Adjuvanten_US
dc.subjectRadiotherapy, Conformalen_US
dc.subjectRadiotherapy, Intensity-Modulateden_US
dc.titleExternal beam radiotherapy for differentiated thyroid cancer.en_US
dc.typeJournal Article
dcterms.dateAccepted2010-03-22en_US
rioxxterms.versionofrecord10.1016/j.clon.2010.03.012en_US
rioxxterms.licenseref.startdate2010-08en_US
rioxxterms.typeJournal Article/Reviewen_US
dc.relation.isPartOfClinical oncology (Royal College of Radiologists (Great Britain))en_US
pubs.issue6en_US
pubs.notesNot knownen_US
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology/Targeted Therapy
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Targeted Therapy
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublisheden_US
pubs.volume22en_US
pubs.embargo.termsNot knownen_US
icr.researchteamTargeted Therapyen_US
dc.contributor.icrauthorHarrington, Kevinen_US
dc.contributor.icrauthorNutting, Chrisen_US
dc.contributor.icrauthorBhide, Shreerangen_US
dc.contributor.icrauthorNewbold, Kateen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record